2025年4月

IF 8 2区 医学 Q1 DERMATOLOGY
{"title":"2025年4月","authors":"","doi":"10.1111/jdv.20604","DOIUrl":null,"url":null,"abstract":"<p></p><p>Jo Lambert</p><p>Isotretinoin's use in rosacea remains limited, although it is known for its anti-inflammatory and sebum reduction properties. Low-dose isotretinoin (LDI; i.e., ≤0.5 mg/kg/day) may be preferred due to fewer adverse events. Here, King et al. reviewed 16 studies to evaluate the efficacy of LDI in rosacea. Their work is foundational for the practicing clinician to rely on when prescribing oral LDI, which has a good safety profile, even over topical monotherapy, as two considered outcome results are better (lesion counts [Figure 1], erythema). Ocular rosacea remains more difficult to treat, and there, oral doxycycline is the best option.</p><p>King, A, Tan, MG, Kirshen, C et al. Low-dose isotretinoin for the management of rosacea: a systematic review and meta-analysis. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:785–792. 10.1111/jdv.20315.</p><p>Hsu et al. retrospectively evaluated rituximab treatment among 123 patients with pemphigus in terms of long-term remission. Concomitant azathioprine and repeated rituximab courses favoured long-term outcomes (Figure 2), while larger body surface areas, higher Pemphigus Disease Area Index, diabetes, and elevated platelets were negative prognostic factors.</p><p>Personally, I was surprised to see that serum anti-desmoglein titers were not deemed a remission-defining factor. Could thrombocytosis pose a negative predictive factor, as rituximab (often used in conditions like idiopathic thrombocytopenic purpura) may increase platelets? In clinic, it remains hard to predict how the treatment scheme for your pemphigus patient may evolve.</p><p>Hsu, HC, Huang, PW, Cho, YT et al. Factors associated with long-term complete remission in pemphigus patients receiving rituximab therapy. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:e313–e316. 10.1111/jdv.20290.</p><p>Bettoli et al. suggest that while ChatGPT provides basic information on acne, it requires expert supervision to ensure accuracy and comprehensiveness (Figure 3). Their study identified several terminological mistakes, which may lead to wrong treatment (e.g. a cyst is not identical to an abscess) and the treatments proposed were not exhaustive. The identified mistakes underline the importance of fact-checking AI-generated content before using it as a reference.</p><p>Future improvements in ChatGPT's performance and the development of more specialized tools may enhance its utility in medical education and patient information dissemination. It does not replace consultation with a healthcare professional.</p><p>Bettoli, V, Naldi, L, Santoro, E et al. ChatGPT and acne: accuracy and reliability of the information provided —the AI-check study. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:e359–e362. 10.1111/jdv.20324.</p><p>Dysmorphic concerns and body dysmorphic disorders (BDD) were found to be five times more frequent in patients with a skin disorder among 5290 patients from 22 European centres, particularly for alopecia, vitiligo, and psoriasis (Table 1). Females tended to experience more dysmorphic concerns; the underlying reason for this deserves qualitative study.</p><p>One can imagine that women are often subject to more intense scrutiny and societal expectations regarding appearance, which can amplify body image concerns. On the other hand, men may underreport body image concerns due to stigma, potentially underestimating and thereby skewing research findings.</p><p>Sampogna F, Samela T, Abeni D, et al. A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical, and psychological variables. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:823–832. 10.1111/jdv.20247.</p>","PeriodicalId":17351,"journal":{"name":"Journal of the European Academy of Dermatology and Venereology","volume":"39 4","pages":"707-708"},"PeriodicalIF":8.0000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.20604","citationCount":"0","resultStr":"{\"title\":\"Editor’s Picks April 2025\",\"authors\":\"\",\"doi\":\"10.1111/jdv.20604\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p></p><p>Jo Lambert</p><p>Isotretinoin's use in rosacea remains limited, although it is known for its anti-inflammatory and sebum reduction properties. Low-dose isotretinoin (LDI; i.e., ≤0.5 mg/kg/day) may be preferred due to fewer adverse events. Here, King et al. reviewed 16 studies to evaluate the efficacy of LDI in rosacea. Their work is foundational for the practicing clinician to rely on when prescribing oral LDI, which has a good safety profile, even over topical monotherapy, as two considered outcome results are better (lesion counts [Figure 1], erythema). Ocular rosacea remains more difficult to treat, and there, oral doxycycline is the best option.</p><p>King, A, Tan, MG, Kirshen, C et al. Low-dose isotretinoin for the management of rosacea: a systematic review and meta-analysis. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:785–792. 10.1111/jdv.20315.</p><p>Hsu et al. retrospectively evaluated rituximab treatment among 123 patients with pemphigus in terms of long-term remission. Concomitant azathioprine and repeated rituximab courses favoured long-term outcomes (Figure 2), while larger body surface areas, higher Pemphigus Disease Area Index, diabetes, and elevated platelets were negative prognostic factors.</p><p>Personally, I was surprised to see that serum anti-desmoglein titers were not deemed a remission-defining factor. Could thrombocytosis pose a negative predictive factor, as rituximab (often used in conditions like idiopathic thrombocytopenic purpura) may increase platelets? In clinic, it remains hard to predict how the treatment scheme for your pemphigus patient may evolve.</p><p>Hsu, HC, Huang, PW, Cho, YT et al. Factors associated with long-term complete remission in pemphigus patients receiving rituximab therapy. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:e313–e316. 10.1111/jdv.20290.</p><p>Bettoli et al. suggest that while ChatGPT provides basic information on acne, it requires expert supervision to ensure accuracy and comprehensiveness (Figure 3). Their study identified several terminological mistakes, which may lead to wrong treatment (e.g. a cyst is not identical to an abscess) and the treatments proposed were not exhaustive. The identified mistakes underline the importance of fact-checking AI-generated content before using it as a reference.</p><p>Future improvements in ChatGPT's performance and the development of more specialized tools may enhance its utility in medical education and patient information dissemination. It does not replace consultation with a healthcare professional.</p><p>Bettoli, V, Naldi, L, Santoro, E et al. ChatGPT and acne: accuracy and reliability of the information provided —the AI-check study. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:e359–e362. 10.1111/jdv.20324.</p><p>Dysmorphic concerns and body dysmorphic disorders (BDD) were found to be five times more frequent in patients with a skin disorder among 5290 patients from 22 European centres, particularly for alopecia, vitiligo, and psoriasis (Table 1). Females tended to experience more dysmorphic concerns; the underlying reason for this deserves qualitative study.</p><p>One can imagine that women are often subject to more intense scrutiny and societal expectations regarding appearance, which can amplify body image concerns. On the other hand, men may underreport body image concerns due to stigma, potentially underestimating and thereby skewing research findings.</p><p>Sampogna F, Samela T, Abeni D, et al. A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical, and psychological variables. <i>J Eur Acad Dermatol Venereol</i>. 2025; <b>39</b>:823–832. 10.1111/jdv.20247.</p>\",\"PeriodicalId\":17351,\"journal\":{\"name\":\"Journal of the European Academy of Dermatology and Venereology\",\"volume\":\"39 4\",\"pages\":\"707-708\"},\"PeriodicalIF\":8.0000,\"publicationDate\":\"2025-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.20604\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the European Academy of Dermatology and Venereology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jdv.20604\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the European Academy of Dermatology and Venereology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jdv.20604","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

尽管索维甲酸以其抗炎和减少皮脂的特性而闻名,但它在酒渣鼻中的应用仍然有限。低剂量异维甲酸;即,≤0.5 mg/kg/天)可能是优选的,因为较少的不良事件。在这里,King等人回顾了16项研究来评估LDI治疗酒渣鼻的疗效。他们的工作是临床医生开口服LDI处方的基础,口服LDI具有良好的安全性,甚至优于局部单药治疗,因为两种被认为的结果更好(病变计数[图1],红斑)。眼部酒渣鼻的治疗仍然比较困难,口服强力霉素是最好的选择。King, A, Tan, MG, Kirshen, C等。低剂量异维甲酸治疗酒渣鼻:系统综述和荟萃分析。中国生物医学工程学报;2009;39:785 - 792。10.1111 / jdv.20315。Hsu等回顾性评估了123例天疱疮患者的利妥昔单抗治疗的长期缓解情况。同时服用硫唑嘌呤和重复的利妥昔单抗有利于长期预后(图2),而较大的体表面积、较高的天疱疮疾病面积指数、糖尿病和血小板升高是负面预后因素。就我个人而言,我很惊讶地发现血清抗粘连蛋白滴度不被认为是缓解的决定性因素。由于利妥昔单抗(常用于特发性血小板减少性紫癜)可能会增加血小板,血小板增多是否构成一个阴性预测因素?在临床,它仍然很难预测如何治疗方案为您的天疱疮患者可能会发展。徐慧聪,黄,PW, Cho, YT等。接受利妥昔单抗治疗的天疱疮患者长期完全缓解的相关因素。中国生物医学工程学报;2009;39: e313-e316。10.1111 / jdv.20290。Bettoli等人认为,虽然ChatGPT提供了关于痤疮的基本信息,但它需要专家监督以确保准确性和全面性(图3)。他们的研究发现了几个术语错误,这可能导致错误的治疗(例如囊肿与脓肿不相同),并且提出的治疗方法并不详尽。这些发现的错误强调了在使用人工智能生成的内容作为参考之前对其进行事实核查的重要性。ChatGPT性能的未来改进和更专业工具的开发可能会增强其在医学教育和患者信息传播方面的效用。它不能代替医疗保健专业人员的咨询。Bettoli, V, Naldi, L, Santoro, E等。ChatGPT和痤疮:所提供信息的准确性和可靠性- ai检查研究。中国生物医学工程学报;2009;39: e359-e362。10.1111 / jdv.20324。在来自22个欧洲中心的5290名患者中,发现患有皮肤病的患者中,畸形担忧和身体畸形障碍(BDD)的发生率高出5倍,特别是脱发、白癜风和牛皮癣(表1)。女性倾向于经历更多的畸形担忧;造成这种情况的根本原因值得进行定性研究。可以想象,女性通常会受到更严格的审查和社会对外表的期望,这可能会放大对身体形象的担忧。另一方面,由于耻辱感,男性可能会低估对身体形象的担忧,这可能会低估并因此扭曲研究结果。李建军,李建军,李建军,等。一项横断面研究,在与社会人口统计学、临床和心理变量有关的皮肤病患者的身体畸形关注的性别差异。中国生物医学工程学报;2009;39:823 - 832。10.1111 / jdv.20247。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Editor’s Picks April 2025

Editor’s Picks April 2025

Jo Lambert

Isotretinoin's use in rosacea remains limited, although it is known for its anti-inflammatory and sebum reduction properties. Low-dose isotretinoin (LDI; i.e., ≤0.5 mg/kg/day) may be preferred due to fewer adverse events. Here, King et al. reviewed 16 studies to evaluate the efficacy of LDI in rosacea. Their work is foundational for the practicing clinician to rely on when prescribing oral LDI, which has a good safety profile, even over topical monotherapy, as two considered outcome results are better (lesion counts [Figure 1], erythema). Ocular rosacea remains more difficult to treat, and there, oral doxycycline is the best option.

King, A, Tan, MG, Kirshen, C et al. Low-dose isotretinoin for the management of rosacea: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2025; 39:785–792. 10.1111/jdv.20315.

Hsu et al. retrospectively evaluated rituximab treatment among 123 patients with pemphigus in terms of long-term remission. Concomitant azathioprine and repeated rituximab courses favoured long-term outcomes (Figure 2), while larger body surface areas, higher Pemphigus Disease Area Index, diabetes, and elevated platelets were negative prognostic factors.

Personally, I was surprised to see that serum anti-desmoglein titers were not deemed a remission-defining factor. Could thrombocytosis pose a negative predictive factor, as rituximab (often used in conditions like idiopathic thrombocytopenic purpura) may increase platelets? In clinic, it remains hard to predict how the treatment scheme for your pemphigus patient may evolve.

Hsu, HC, Huang, PW, Cho, YT et al. Factors associated with long-term complete remission in pemphigus patients receiving rituximab therapy. J Eur Acad Dermatol Venereol. 2025; 39:e313–e316. 10.1111/jdv.20290.

Bettoli et al. suggest that while ChatGPT provides basic information on acne, it requires expert supervision to ensure accuracy and comprehensiveness (Figure 3). Their study identified several terminological mistakes, which may lead to wrong treatment (e.g. a cyst is not identical to an abscess) and the treatments proposed were not exhaustive. The identified mistakes underline the importance of fact-checking AI-generated content before using it as a reference.

Future improvements in ChatGPT's performance and the development of more specialized tools may enhance its utility in medical education and patient information dissemination. It does not replace consultation with a healthcare professional.

Bettoli, V, Naldi, L, Santoro, E et al. ChatGPT and acne: accuracy and reliability of the information provided —the AI-check study. J Eur Acad Dermatol Venereol. 2025; 39:e359–e362. 10.1111/jdv.20324.

Dysmorphic concerns and body dysmorphic disorders (BDD) were found to be five times more frequent in patients with a skin disorder among 5290 patients from 22 European centres, particularly for alopecia, vitiligo, and psoriasis (Table 1). Females tended to experience more dysmorphic concerns; the underlying reason for this deserves qualitative study.

One can imagine that women are often subject to more intense scrutiny and societal expectations regarding appearance, which can amplify body image concerns. On the other hand, men may underreport body image concerns due to stigma, potentially underestimating and thereby skewing research findings.

Sampogna F, Samela T, Abeni D, et al. A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical, and psychological variables. J Eur Acad Dermatol Venereol. 2025; 39:823–832. 10.1111/jdv.20247.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.70
自引率
8.70%
发文量
874
审稿时长
3-6 weeks
期刊介绍: The Journal of the European Academy of Dermatology and Venereology (JEADV) is a publication that focuses on dermatology and venereology. It covers various topics within these fields, including both clinical and basic science subjects. The journal publishes articles in different formats, such as editorials, review articles, practice articles, original papers, short reports, letters to the editor, features, and announcements from the European Academy of Dermatology and Venereology (EADV). The journal covers a wide range of keywords, including allergy, cancer, clinical medicine, cytokines, dermatology, drug reactions, hair disease, laser therapy, nail disease, oncology, skin cancer, skin disease, therapeutics, tumors, virus infections, and venereology. The JEADV is indexed and abstracted by various databases and resources, including Abstracts on Hygiene & Communicable Diseases, Academic Search, AgBiotech News & Information, Botanical Pesticides, CAB Abstracts®, Embase, Global Health, InfoTrac, Ingenta Select, MEDLINE/PubMed, Science Citation Index Expanded, and others.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信